|
The Board of Henderson Morley announces
that, further to the announcement made on 23 January 2007,
the Company is continuing to explore strategic options in
order to maximise shareholder value. One of these options
is the sale of some or all of the business, and the Board
has engaged advisers to assist with this process. This
process may or may not lead to an offer being made for the
Company. Consequently the Company is considered to be in
an “offer period” as defined in the City Code on Takeovers
and Mergers, and the dealing disclosure requirements
listed below will apply.
During this process the scientific development programme
and out-licensing strategy continues unaffected.
The Company will keep shareholders informed of progress in
this respect. |